Afatinib Sequenced With Concurrent Chemotherapy and Radiation in EGFR-Mutant Non-Small Cell Lung Tumors: The ASCENT Trial
Phase of Trial: Phase II
Latest Information Update: 23 Sep 2017
At a glance
- Drugs Afatinib (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms ASCENT
- 10 Jun 2017 Biomarkers information updated
- 23 Sep 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2018.
- 17 Jun 2013 Planned end date changed from 1 Apr 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.